Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.550
-0.130 (-3.53%)
Mar 6, 2026, 4:00 PM EST - Market closed
MRVI Market Cap
MRVI has a market cap or net worth of $912.59 million as of March 6, 2026. Its market cap has increased by 57.69% in one year.
Market Cap
912.59M
Enterprise Value
1.07B
1-Year Change
57.69%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $912.59M, a decrease of -62.43%. That is a compound annual growth rate of -16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 538.69M | 14.29% |
| Dec 31, 2025 | 471.32M | -39.03% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 987.94M |
| Geron | 980.03M |
| SELLAS Life Sciences Group | 941.66M |
| Cullinan Therapeutics | 929.86M |
| Valneva SE | 920.15M |
| Fortrea Holdings | 898.54M |
| ARS Pharmaceuticals | 895.57M |
| SpyGlass Pharma | 888.91M |